Capital DailyCapital Daily
Finance

Nano Nuclear Energy vs. NuScale Power: Which Nuclear Energy Stock Is a Better Buy in 2026?

Nano Nuclear Energy bets on microreactor mobility, while NuScale Power leverages its regulatory edge, both face steep losses and commercialization hurdles.

Nano Nuclear Energy vs. NuScale Power: Which Nuclear Energy Stock Is a Better Buy in 2026?

Nano Nuclear Energy vs. NuScale Power: Which Nuclear Energy Stock Is a Better Buy in 2026?

Published June 25, 2026 · Category: Finance

Overview

Nuclear power is undergoing a renaissance. As global energy demands rise, choosing between Nano Nuclear Energy (NASDAQ:NNE) and NuScale Power (NYSE:SMR) means weighing early-stage microreactor innovation against a more established small modular reactor leader.

Nano Nuclear Energy targets the portable microreactor niche, while NuScale Power focuses on larger-scale modular designs for utilities. Both companies represent high-risk plays in the nuclear renaissance, seeking to revolutionize carbon-free baseload power through different technical pathways.

Details

Nano Nuclear Energy develops portable microreactor technologies, including the KRONOS and ZEUS systems, designed for remote industrial and military use. The company also manages nuclear fuel fabrication and transportation services through collaborations with the University of Illinois and LIS Technologies. Because the firm currently has no definitive commercial customer agreements for its reactor lines, it faces significant customer concentration risks as it seeks its first major contracts.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.